Eversept Partners, LP
NEW YORK, NY · CIK 1697013 · 13F filing filed 2024-02-14
SEC-registered investment adviser since 2017 · limited partnership
- Assets managed$2.7bn
- Staff10 · 5 in investment roles
- Main clients (by assets)Private funds 99%, Mutual funds and ETFs 1%
- Private funds3 (3 hedge) · $2.3bn gross assets
- Websiteeversept.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityEVERSEPT PARTNERS, L.P. (US)
- Kindhedge funds, futures
- Others nearbyNew York, NY, San Francisco, CA
As an employer
- Offices in1 country
- Private fundshedge 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 4 |
| San Francisco, CAUnited States | 1 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Options: 0 call positions (— notional), 2 put positions ($118.5m notional) – listed below, not included above.
Holdings, Q4 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| NATERA INC NTRA | $141.0m13.83% | Reduced -241.0k |
| GSK PLC GSK | $110.2m10.80% | Reduced -286.4k |
| SYNDAX PHARMACEUTICALS INC SNDX | $73.1m7.17% | Added +787.0k |
| INSPIRE MED SYS INC INSP | $71.4m7.00% | Added +158.1k |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | $64.3m6.30% | Reduced -797.7k |
| UNITED THERAPEUTICS CORP DEL UTHR | $54.1m5.31% | Reduced -21.7k |
| BIO-TECHNE CORP TECH | $35.9m3.52% | Added +79.4k |
| HEALTHEQUITY INC HQY | $32.8m3.22% | Added +156.4k |
| ARGENX SE ARGX | $32.7m3.20% | Added +81.3k |
| HCA HEALTHCARE INC HCA | $31.1m3.05% | Added +4.7k |
| CELLDEX THERAPEUTICS INC NEW CLDX | $29.9m2.93% | Added +166.0k |
| VERA THERAPEUTICS INC VERA | $29.5m2.89% | Added +436.3k |
| COMMUNITY HEALTH SYS INC NEW CYH | $22.6m2.22% | Added +85.0k |
| IMMUNOGEN INC IMGN | $22.2m2.18% | New |
| REVVITY INC RVTY | $20.0m1.96% | Added +150.4k |
| IONIS PHARMACEUTICALS INC IONS | $16.4m1.61% | Added +72.2k |
| VAXCYTE INC PCVX | $14.7m1.44% | Added +43.4k |
| SHOCKWAVE MED INC SWAV | $14.4m1.42% | Reduced -8.6k |
| TENET HEALTHCARE CORP THC | $14.2m1.39% | New |
| PROTAGONIST THERAPEUTICS INC PTGX | $12.3m1.21% | Added +251.3k |
| ILLUMINA INC ILMN | $12.1m1.18% | Reduced -80.2k |
| TARO PHARMACEUTICAL INDS LTD TARO | $10.7m1.05% | Added +665 |
| KRYSTAL BIOTECH INC KRYS | $10.0m0.98% | Reduced -28.0k |
| ZIMVIE INC ZIMV | $9.7m0.95% | New |
| DANAHER CORPORATION DHR | $9.5m0.93% | Reduced -62.7k |
| BIOCRYST PHARMACEUTICALS INC BCRX | $9.2m0.90% | Reduced -950.1k |
| WATERS CORP WAT | $9.1m0.89% | Added +4.6k |
| LIQUIDIA CORPORATION LQDA | $8.3m0.81% | Reduced -706.5k |
| PUMA BIOTECHNOLOGY INC PBYI | $7.3m0.72% | Added +13.9k |
| CENTENE CORP DEL CNC | $7.2m0.71% | Reduced -93.4k |
| ELEVANCE HEALTH INC ELV | $7.1m0.70% | Reduced -6.6k |
| TAYSHA GENE THERAPIES INC TSHA | $6.7m0.66% | Added +2.1m |
| GOSSAMER BIO INC GOSS | $5.9m0.58% | Added +2.0m |
| AMARIN CORP PLC SPONS ADR NEW | $5.3m0.52% | Reduced -2.3m |
| AGILENT TECHNOLOGIES INC A | $5.3m0.52% | Reduced -4.0k |
| 2SEVENTY BIO INC TSVT | $4.9m0.48% | Reduced -314.3k |
| IMMUNOVANT INC IMVT | $4.8m0.47% | New |
| SUTRO BIOPHARMA INC COM | $4.5m0.44% | Added +286.8k |
| ICON PLC ICLR | $4.4m0.43% | Reduced -5.6k |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $4.2m0.41% | Reduced -286.2k |
| MERUS N V MRUS | $3.2m0.31% | Reduced -18.3k |
| VIRIDIAN THERAPEUTICS INC VRDN | $3.0m0.29% | Reduced -305.9k |
| AVANTOR INC AVTR | $2.9m0.28% | Added +41.5k |
| BIOHAVEN LTD BHVN | $2.9m0.28% | Reduced -64.2k |
| IQVIA HLDGS INC IQV | $2.8m0.28% | Reduced -10.8k |
| SERES THERAPEUTICS INC COM | $2.5m0.24% | Reduced -599.0k |
| MOLINA HEALTHCARE INC MOH | $2.2m0.22% | Reduced -6.1k |
| INFLARX NV IFRX | $2.1m0.21% | Reduced -432.4k |
| CUREVAC N V CVAC | $2.1m0.21% | Reduced -19.9k |
| REPLIGEN CORP RGEN | $1.8m0.18% | Reduced -6.2k |
| XOMA ROYALTY CORPORATION XOMA | $1.7m0.17% | Added +3.8k |
| AEROVATE THERAPEUTICS INC COM | $1.1m0.11% | Unchanged |
| AFFIMED N V COM | $1.0m0.10% | Unchanged |
| HUMANA INC HUM | $876.2k0.09% | Reduced -16.2k |
| AC IMMUNE SA ACIU | $622.9k0.06% | Unchanged |
Sold out since Q3 2023
| Security | Value then |
|---|---|
| HORIZON THERAPEUTICS PUB L HZNP | $23.8m205.8k shares |
| AMNEAL PHARMACEUTICALS INC AMRX | $11.2m2.6m shares |
| APELLIS PHARMACEUTICALS INC APLS | $4.7m122.6k shares |
| MARAVAI LIFESCIENCES HLDGS I MRVI | $4.5m452.3k shares |
| PENNANT GROUP INC PNTG | $4.1m365.9k shares |
| INSULET CORP PODD | $3.4m21.3k shares |
| MEDPACE HLDGS INC MEDP | $2.1m8.8k shares |
| SPDR SER TR XBI | $1.5m20.0k shares |
| BLACK DIAMOND THERAPEUTICS I BDTX | $967.6k337.1k shares |
| AADI BIOSCIENCE INC WHWK | $493.3k101.9k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| INVESCO QQQ TR QQQ · Put | $61.4m150.0k shares | Reduced |
| SPDR S&P 500 ETF TR SPY · Put | $57.0m120.0k shares | Reduced |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 | 5.7%≈ $26.5m |